Toward precision microbiome therapeutics: From black box to blueprint

Area of Science:

• Microbiology
• Genetics
• Therapeutics

Background:

• The gut microbiome significantly impacts human health.
• Current metagenomics approaches identify microbes but lack functional network insights.
• Previous microbiome "reset" therapies showed clinical benefits with limited mechanistic understanding.

Purpose of the Study:

• To highlight a critical advancement in microbiome therapeutics.
• To propose in situ genome editing as a programmable, species-specific therapeutic strategy.
• To bridge the gap between microbial identification and functional understanding for targeted treatments.

Main Methods:

• Conceptual framework outlining the potential of in situ genome editing.
• Discussion of mechanism-driven, programmable, and species-specific therapeutic design.
• Argument for a shift towards precise genetic manipulation of native gut bacteria.

Main Results:

• In situ genome editing enables precise modification of native gut bacteria.
• This technology facilitates the development of mechanism-driven microbiome therapeutics.
• Programmable, species-specific interventions are now feasible.

Conclusions:

• In situ genome editing represents a paradigm shift in microbiome-based therapies.
• This approach allows for targeted and mechanistic interventions.
• It paves the way for highly specific and effective gut microbiome treatments.